Bharat Biotech’s ‘Covaxin’ to use ViroVax’s adjuvant for boosting immunity response
Bharat Biotech declared Covaxin would utilize adjuvant Alhydroxiquim-II to improve immune response. The ViroVax is supported by the National Institute ...
Bharat Biotech declared Covaxin would utilize adjuvant Alhydroxiquim-II to improve immune response. The ViroVax is supported by the National Institute ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily